Unichem Laboratories’ formulation manufacturing facility at Ghaziabad was inspected by the US Food and Drug Administration (USFDA) from April 16, 2018 to April 20, 2018. The inspection concluded with zero observations. This inspection also covered one of the first to file molecules.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
